Results 151 to 160 of about 20,015 (204)

Ghrelin receptor in agouti-related peptide neurones regulates metabolic adaptation to calorie restriction. [PDF]

open access: yesJ Neuroendocrinol, 2019
Wu CS   +8 more
europepmc   +1 more source

Ghrelin Receptor Signaling Is Not Required for Glucocorticoid-Induced Obesity in Male Mice.

open access: yesEndocrinology, 2020
Hay RE   +7 more
europepmc   +1 more source

Physiological roles revealed by ghrelin and ghrelin receptor deficient mice [PDF]

open access: yesPeptides, 2011
Ghrelin is a hormone made in the stomach and known primarily for its growth hormone releasing and orexigenic properties. Nevertheless, ghrelin through its receptor, the GHS-R1a, has been shown to exert many roles including regulation of glucose homeostasis, memory & learning, food addiction and neuroprotection.
Yuxiang Sun, Roy G Smith
exaly   +3 more sources

LEAP2 Is an Endogenous Antagonist of the Ghrelin Receptor [PDF]

open access: yesCell Metabolism, 2018
Ghrelin, an appetite-stimulatory hormone secreted by the stomach, was discovered as a ligand for the growth hormone secretagogue receptor (GHSR). Through GHSR, ghrelin stimulates growth hormone (GH) secretion, a function that evolved to protect against starvation-induced hypoglycemia.
Lutz Jermutus   +2 more
exaly   +3 more sources

Ghrelin and cannabinoids require the ghrelin receptor to affect cellular energy metabolism

open access: yesMolecular and Cellular Endocrinology, 2013
Ghrelin is a potent orexigenic brain-gut peptide with lipogenic and diabetogenic effects, possibly mediated by growth hormone secretagogue receptor (GHS-R1a). Cannabinoids also have orexigenic and lipogenic effects. AMPK is a regulator of energy homeostasis and we have previously shown that ghrelin and cannabinoids stimulate hypothalamic AMPK activity ...
Diego Pérez-Tilve   +2 more
exaly   +3 more sources
Some of the next articles are maybe not open access.

Related searches:

Ghrelin Receptors and Epilepsy

2014
Epilepsy is a neurological disorder that affects more than 50 million people worldwide. One-third of all epilepsy patients do not respond to the antiepileptic medications that are currently available. As such, there is a great need for new, more effective drugs for the treatment of epilepsy.
Portelli, Jeanelle   +3 more
openaire   +2 more sources

Ghrelin and ghrelin receptor inhibitors: agents in the treatment of obesity

Expert Opinion on Therapeutic Targets, 2008
Current medical treatment of obesity is highly ineffective. Soon after its discovery as the endogenous ligand for the growth hormone secretagogue-receptor (GHS-R), ghrelin was shown to stimulate food intake (including in humans) and promote body weight gain and adipogenesis.This review discusses the role of the ghrelin/GHS-R pathway in energy ...
João-Bruno, Soares   +2 more
openaire   +2 more sources

Ghrelin Receptor Modulators and Their Therapeutic Potential

Future Medicinal Chemistry, 2009
Ghrelin is a peptide produced predominantly in the stomach and intestines, and is a natural growth hormone (GH) secretagogue-receptor ligand. It is able to stimulate GH release, but it also exhibits an important role in conditions related to processes regulating nutrition, body composition and growth, and heart, liver, thyroid or kidney dysfunction ...
COSTANTINO, Luca, D. Barlocco
openaire   +3 more sources

Home - About - Disclaimer - Privacy